Entries by Morgana Souza

U.S. and Johnson & Johnson Commit $1B to Vaccine Trial

“We are moving forward as fast as we possibly can … If everything goes well — and that's a big if — [then] the vaccine may be ready for emergency use authorization in early 2021,” says Dr. Dan Barouch, who helped develop a potential coronavirus vaccine. https://t.co/RzYfWUjJwT pic.twitter.com/CYOrMzh8C7 — CNN Newsroom (@CNNnewsroom) April 2, 2020 […]

Ending the Pandemic

“The stunning epidemiology and clinical features of COVID-19, particularly the potential for explosive and asymptomatic spread, increase the chance that a vaccine may actually be required to end this epidemic,” said Dan Barouch. Read Article

BIOQUAL Announces COVID-19 Vaccine Testing

BIOQUAL announces the development of programs for in-vivo testing of COVID-19 candidate vaccines. BIOQUAL’s efforts to develop animal models for COVID-19 began in February 2020 in collaboration with Dr. Dan Barouch at Beth Israel Deaconess Medical Center and the Ragon Institute, both affiliated with Harvard Medical School. Read More